Gene · 9475
Papers3,801
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,801
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Angiocrine signaling drives liver fibrosis: From mechanism to early clinical translation. | Cell | 2026 | 42066745 | PubTator, text mining | PubMed |
| ECE1c promotes glioblastoma invasion via the ROCK2-MYH10 axis and interaction with ACTB. | Am J Transl Res | 2026 | 42007117 | PubTator, text mining | PubMed |
| Discovery of N‑Acylhydrazone Derivatives as ROCK Inhibitors: A Journey from Virtual Screening and Structure-Based De Novo Design to the Identification of ROCK2 Selective Inhibitors and Beyond. | ACS Bio Med Chem Au | 2026 | 42006256 | PubTator, text mining | PubMed |
| GAK antagonises ROCK-dependent regulation of actomyosin dynamics. | J Cell Sci | 2026 | 41995027 | PubTator, text mining | PubMed |
| Identifying genes related to olfaction in the antennae of Samia cynthia Drury (Lepidoptera: Saturniidae) via de novo transcriptome assembly. | J Econ Entomol | 2026 | 41964646 | PubTator, text mining | PubMed |
| Cellular and Molecular Neuro-Bone Cell Interactions Drive Alveolar Bone Remodeling During Orthodontic Mechanical Loading. | Int J Biol Sci | 2026 | 41943840 | PubTator, text mining | PubMed |
| Salvage nintedanib plus low-dose ruxolitinib therapy for bronchiolitis obliterans syndrome refractory to calcineurin inhibitors and glucocorticoids after allogeneic transplantation. | Cell Transplant | 2026 | 41934132 | PubTator, text mining | PubMed |
| The role of Rho-associated coiled-coil kinases (ROCK) in cancer. | Oncogene | 2026 | 41933134 | PubTator, text mining | PubMed |
| ROCK2 is a druggable angiocrine target in liver fibrosis. | Nat Rev Drug Discov | 2026 | 41912681 | PubTator, text mining | PubMed |
| A20 enhances the migration and metastasis of gastric cancer cells by promoting occludin degradation. | Cell Death Discov | 2026 | 41904194 | PubTator, text mining | PubMed |
Correction: Tonon et al. 5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 Pathway. Cancers 2022, 14, 1630. | Cancers (Basel) | 2026 | 41899647 | PubTator, text mining | PubMed |
| RhoGEF12 regulates endosomal SORL1-retromer and its inhibition is therapeutic in human neuronal models of Alzheimer's disease. | bioRxiv | 2026 | 41889823 | PubTator, text mining | PubMed |
| Hypertension-Associated Acetate Deficiency Enhances Platelet Activation and Thrombosis Via Olfr78. | Circ Res | 2026 | 41878811 | PubTator, text mining | PubMed |
| EBV infection outcomes determined by monocyte and TREG-driven immune dynamics in an ex vivo pbmc model. | PLoS Pathog | 2026 | 41860926 | PubTator, text mining | PubMed |
| The JMJD family histone demethylases: structure, mechanism of action, diseases and therapeutic targets. | Mol Biomed | 2026 | 41857315 | PubTator, text mining | PubMed |
| TBXA2R activates ERMs to drive motility, invasion, and metastatic colonization of TNBC cells. | Life Sci Alliance | 2026 | 41844278 | PubTator, text mining | PubMed |
| The telomerase reverse transcriptase-derived peptide GN11 alleviates glycolysis and cellular senescence in the fibrotic kidney by inhibiting the TGF-β1/Smad3/lncRNA Oip5-os1/miR-30c-5p/Rock2 axis. | Biochem Pharmacol | 2026 | 41839244 | PubTator, text mining | PubMed |
| Exploratory evaluation of CAP1 and ROCK2 as candidate blood biomarkers for vascular cognitive impairment. | J Alzheimers Dis | 2026 | 41837796 | PubTator, text mining | PubMed |
| Brain Permeable SGK1 Inhibitors: A Promising Therapeutic Strategy for Neurodegenerative Diseases. | J Med Chem | 2026 | 41837733 | PubTator, text mining | PubMed |
| Picalm coordinates clathrin-mediated endocytosis and actin remodeling during myogenesis. | Mol Metab | 2026 | 41833602 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9475/papers?page=3